Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.

NCT02133118 · clinicaltrials.gov ↗

COMPLETED

Status

16293

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: individual SUs, insulin, pioglitazone

Sponsor

Medical Research Foundation, The Netherlands